| Name | Title | Contact Details |
|---|
Kedrion Biopharma develops and produces plasma-derived therapies, making them available to meet patients` needs the world over. We collect and fractionate blood plasma for the development, production and distribution of plasma derivatives used in the treatment of patients suffering from rare and chronic conditions such as hemophilia and immune system deficiencies. A corporation is not a person, but a corporation is run by people and it affects people. And Kedrion`s business is people. The very nature of our enterprise is to help people live more full and healthy lives. This commitment extends to how we conduct our business, that is, in ways that are consistent with our mission: to build bridges that.benefit people. Long a major player in the plasma derivatives sector in Italy, as partner with the Italian Health System, Kedrion has now become an international participant in the industry with a market presence in about 100 countries. We have plants in Italy, Hungary and the United States and plasma collection centers in the U.S., Germany and Hungary. Kedrion looks forward to continued expansion and the wider sharing of its experience, know-how and technology to foster self-sufficiency of plasma-derived therapies worldwide and to bring healthier and less restricted lives to people suffering from rare disorders. Kedrion Biopharma produces wealth for investors, employees and for the local community, consistent with its own vision and values: responsibility, transparency, confidence in and respect for people. Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. Kedrion Biopharma builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.
The patient adherence software platform for pharmaceutical brands. Use gamification, behavioral economics & loyalty marketing to drive patient adherence.
Cap Management Systems is a Encino, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
As an integrated, not-for-profit organization, CentraCare is working to improve the lives and wellbeing of those living in Central Minnesota. CentraCare provides care through hospitals located in St. Cloud, Long Prairie, Melrose, Monticello, Paynesville and Sauk Centre with more than 25 clinics and specialty centers throughout the region. Additionally, Carris Health, a wholly-owned subsidiary of CentraCare, is comprised of Rice Memorial Hospital in Willmar, Redwood Hospital in Redwood Falls and seven clinics in the Southwest and West Central region of the state. CentraCare – St. Cloud Hospital has been a Magnet-designated hospital since 2004 and repeatedly receives national recognition for its outstanding quality measures. CentraCare provides comprehensive primary through tertiary care, CentraCare also operates numerous specialty services, including the CentraCare Heart & Vascular Center, Coborn Cancer Center and the CentraCare Kidney Program. CentraCare serves all who seek care with compassion, dignity and respect, while seeking to enhance individual and community health. Mission: CentraCare Health works to improve the health of every patient, every day. Vision: CentraCare Health will be the leader in Minnesota for quality, safety, service and value. Core Values: •Patient Centered: Serving patients above all. •Integrity: Adhering to honest and ethical practices. •Collaboration: Working jointly with others to improve health and health care. •Compassion: Serving all who seek our care with kindness, dignity, and respect. •Stewardship: Ensuring responsible use of all resources to best serve our communities.
Uroplasty is a global medical company committed to offering transformative treatment options through specialty physicians. Our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices. Uroplasty’s products include the Urgent® PC Neuromodulation System, a non-drug, non-surgical office-based treatment for Overactive Bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Urgent PC is an FDA-cleared system that delivers PTNS (Percutaneous Tibial Nerve Stimulation) and is also indicated for the treatment of fecal incontinence outside the US market. Uroplasty also offers Macroplastique®, an injectable urethral bulking agent for female stress urinary incontinence primarily due to intrinsic sphincter deficiency. Female SUI only in U.S.; male and female SUI outside the U.S. Uroplasty products are typically used when a patient’s treatment goals are not met after conservative and/or drug therapies. Providers and patients alike appreciate that Uroplasty products provide low-risk, effective alternatives to invasive surgery. And because these treatments can be delivered in an office or outpatient setting, the end result is that more patients are given the opportunity to transform their lives with successful treatment.